- Mink, S.A., Amitage, J.O (2001) "High-dose therapy in lymphomas: a review of the current status of allogeneic and autologous stem cell transplantation in Hodgkin's disease and non-Hodgkin's lymphoma", The Oncologist 6, 247-256.
- Armitage, J.O. (2000) "High-dose chemotherapy and autologous hematopoietic stem cell transplantation: the lymphoma experience and its potential relevance to solid tumors", Oncology 58, 198-206.
- Vose, J.M. (1998) "High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphoma", Annals of Oncology 9(Suppl. 1). S1-S3.
- Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn. J.Y., Harousseau, J.L. (1995) "Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma", New England Journal of Medicine 333, 1540-1545.
- Cagnoni, P.J. and Shpall. E.J. (1996) "Mobilization and selection of CD34-positive hematopoietic progenitors", Blood Review 10, 1-7.
- Stadtmauer, E.A., Schneider. C.J. and Silberstein, L.E. (1995) "Peripheral blood progenitor cell generation and harvesting", Seminars in Oncology 22, 291-300.
- To, L.B., Haylock, D.M., Simmons, P.J. and Juttner, C.A. (1997) "The biology and clinical uses of blood stem cells", Blood 89, 2233-2258.
- Leitman, S.F. and Read, E.J. (1996) "Hematopoietic progenitor cell", Seminars in Hemulology 33, 341-358.
- Demirer, T., Buckner, C.D., Gooley, T., Appkelbaum, F.B., Rowley, S., Chauncey, T., Lilieby, K., Storb, R., Bensinger, W.I. (1996) "Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma", Bone Marrow Transplanlion 17, 937-941.
- Lie, A.K., Rawling, T.P., Bayly, J.L. and To, L.B. (1996) "Progenitor cell yield in sequential blood stem cell mobilization in the same patients: insights into chemotherapy dose escalation and combination of haemopoietic growth factor and chemotherapy", British Journal of Haematology 95, 39-44.
- Narayanasami, U., Kantet,. R., Morelli, J., Klekar, A., Al-Olama, A., Keating, C., O'Connor, C., Berkman, E., Erban, J.K., Sprague, K.A., Miller, K.B. and Schenkein, D.P. (2001) "Randomized trial of filgrastiin versus chemotherapy and filgrastim mobilization of hematopoieric progenitor cells for rescue in autologous transplantation", Blood 98, 2059-2064.
- Sugrue, M.W., Williams, K., Pollock, B.H., Khan, S., Peracha, S., Wingard, J.R. and Moreb, J.S. (2000) "Characterization and outcome of hard to mobilize lymphoma patients undergoing autologous stem cell transplantation", Leukemia and Lymphoma 39. 509-519.
- Kaplan, E. and Meier, P. (1958) "Nonparametric estimation from incomplete observations", Journal of American Statistics Association 135, 186-206.
- Cox, D.R. (1972) "Regression models and life tables", Journal of Research Statistical Society 34, 187-220.
- Ketterer, N., Salles, G., Moullet. I., Dumontet, C., ElJaafari-Corbin, A., Tremisi, P., Thieblemont, C., Durand, B, Neidhanlt-Berard, E.M., Samaha, H., Rigal, D. and Coiffier, B. (1998) "Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with Iymphoid malignancies", British Journal of Haematology 103, 235-242.
- Haas, R., Mohle, R., Fruhauf, S., Goldschmidt, H., Witt, B., Flentje, M., Wanneamacher, M. and Himstein, W. (1994) "Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lyruphoma", Blood 3, 3787-3794.
- Passos-Coelho, J.L., Braine, H.G., Davis, J.M., Huelskamp, A.M., Schepers, K.G., Ohly, K. Clarke, B., Wright, S.K., Noga, S.J., Davidson, N.E. (1995) "Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colonystimulating factor mobilization", Journal of Clinical Oncology 13, 705-714.
- Bensinger, W., Appelbaum, E., Rowley, S., Storb, R., Sanders, J., Lilleby, K., Gooley, T., Demirer, T., Schiffman, K., Weaver, C. (1995) "Factors that influence collection and engraftment of autologous peripheral-blood stem cells", Journal of Clinical Oncology 13, 2547-2555.
- Dreger, P., Kloss, M., Peterson, B., Haferlach, T., Loffler, H., Loeffler, M. and Schmilz, N. (1997) "Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts", Blood 86, 3970-3978.
- Weaver, C.H., Potz, J., Redmond, J., Tauer, K., Schwartzberg, L.S., Kaywin, P., Drapkin, R., Grant, B., Unger, P., Allen, C., Longin, K., Zhen, B., Hazelton, B. and Buckner, C.D. (1997) "Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell content", Bone Marrow Transplantion 19, 1103-1110.
- Gordan, L.N., Sugrue, M.W., Williams, K.D., Khan S.A., Wingard J.R., Moreb J.S. (2001) "Correlation of absolute lymphocyte count recovery and CD34+ cell dose after autolognus stem-cell transplant in patients with Hodgkin's and non-Hodgkin's lymphoma", Blood 98, 681a.
- Porrata, L.F., Gertz, M.A., Inwards, D.J., Litzow, M.R., Lacy, M.Q., Tefferi, A., Gastineau, D.A., Dispenzieri, A., Ansell, S.M., Micallef, I.N., Geyer, S.M. and Markovic. S.N. (2001) "Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma", Blood 98, 579-585.
- Stockerl-Goldstein, K.E., Reddy, S.A., Homing, S.F., Blume, K.G., Chao, N.F., Hu, W.W., Johnston. L.F., Long, G.D., Strober, S., Wong, R.M., Feiner, R.H., Kobler, S. and Negrin, R.S. (2000) "Favorable treatment outcome in non-Hodgkin's lymphoma patients with poor mobilization of peripheral blood progenitor cells", Biology of Blood and Marrow Transplantion 6, 506-512.
- Schimmer, A.D., Jamal, S., Messner, H., Keating. A., Mcharchand, J., Huebsch, L., Walker, L. Benger. A., Gluck, S. and Smith, A. (2000) "Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): results of a provincial strategy. Ontario BMT Network. Canada", Bone Marrow Transplantion 26, 859-864.
Poor Mobilization of Peripheral Blood Stem Cells is a Risk Factor for Worse Outcome in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.